There are 383 resources available
25P - Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping
Presenter: James Chih-Hsin Yang
Session: Poster Display session
26P - Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung cancer (aNSCLC): Updated results from GEOMETRY mono-1
Presenter: Jurgen Wolf
Session: Poster Display session
27P - Durability of efficacy and safety with selpercatinib in patients (pts) with RET Fusion+ non-small cell lung cancer (NSCLC)
Presenter: Alexander Drilon
Session: Poster Display session
28P - Dose determination and pharmacokinetics (PK) of pralsetinib: Results from the phase I ARROW study
Presenter: Justin Gainor
Session: Poster Display session
Live closing remarks
Presenter: Nicolas Girard
Session: Closing session
Resources:
Webcast
Introduction and first vote
Presenter: Suresh Ramalingam
Session: Duration of IO: Limited vs forever
Resources:
Webcast
Limited
Presenter: Benjamin Besse
Session: Duration of IO: Limited vs forever
Resources:
Slides
Webcast
Forever
Presenter: Helena Linardou
Session: Duration of IO: Limited vs forever
Resources:
Webcast
Second vote and conclusions
Presenter: Suresh Ramalingam
Session: Duration of IO: Limited vs forever
Resources:
Webcast
A second life for vaccines?
Presenter: Lyudmila Bazhenova
Session: New roads in I-O
Resources:
Slides
Webcast